The Effect of Malaria and HIV Co-Infection on Anemia
Authors:
- Nisha Kaur SandhuNSNisha Kaur Sandhu
- Victor Nyunt WaiVWVictor Nyunt Wai
Open Access
- 1 April 2016
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 95 (14) , e3205
Abstract
Malaria and human immunodeficiency virus (HIV) infections are globally important public health concerns. The objectives of this study were (i) to determine the prevalence of malaria and HIV co-infections in people living in endemic countries, and (ii) to assess the effect of co-infection on anemia.Studies were searched on electronic databases including PubMed, Embase, Medline, Google Scholar, and African Journals Online. Observational studies, assessing the prevalence of co-infection and reporting its association with anemia, were included. The methodological quality of included studies was assessed using a tool called the risk of bias assessment for non-randomized studies. Heterogeneity among studies was investigated with the I-square test. Pooled prevalence of the co-infection and its 95% confidence interval (CI) were estimated using the random-effect model, reflected on heterogeneity among studies. Summary odds ratio (OR), summary standardized mean difference (SMD), and their corresponding 95% CIs were estimated, as appropriate. Subgroup analysis and meta-regression were performed for robustness of results. Publication bias was assessed by visualization of a funnel plot.Twenty-three studies were included in the present study. Overall, the pooled prevalence of co-infection was 19% (95% CI: 15-23%, I: 98.1%), showing 26% (95% CI: 20-32%, I: 98.7%) in adults, 12% (95% CI: 7-17%, I: 95.0) in pregnant women, and 9% (95% CI: 6-11%, I: 68.6%) in children. Anemia was comparable between the monoinfected and co-infected adults (summary OR: 1.49, 95% CI: 0.93-2.37) and increased by 49% in co-infected pregnant women (summary OR: 1.49, 95% CI: 1.14-1.94). The mean hemoglobin concentration was significantly lower in the co-infected group than the monoinfected group (summary SMD: -0.47, 95% CI: -0.61 to -0.33). The results of meta-regression on the prevalence of co-infection using the publication year and total population as covariates showed the I value remained high implying a de facto random distribution of heterogeneity. An asymmetrical funnel plot indicated the presence of publication bias. Due to heterogeneity of the studies in this review, the results have to be interpreted with caution.The findings of this study suggest that the prevalence of malaria and HIV co-infection, particularly in pregnant women, requires special attention from healthcare personnel. Better understanding of the co-infection is crucial for designing treatment strategies. Future well-powered, prospective designs assessing the interaction between malaria and HIV are recommended.Keywords
This publication has 65 references indexed in Scilit:
- Impact of Malaria on Hematological Parameters in People Living with HIV/AIDS Attending the Laquintinie Hospital in Douala, CameroonPLOS ONE, 2012
- Diagnosis, Clinical Presentation, and In-Hospital Mortality of Severe Malaria in HIV-Coinfected Children and Adults in MozambiqueClinical Infectious Diseases, 2012
- P. falciparum Enhances HIV Replication in an Experimental Malaria Challenge SystemPLOS ONE, 2012
- The anaemia of Plasmodium vivax malariaMalaria Journal, 2012
- No Evidence of Association between HIV-1 and Malaria in Populations with Low HIV-1 PrevalencePLOS ONE, 2011
- Different Regions of HIV-1 Subtype CenvAre Associated with Placental Localization andIn UteroMother-to-Child TransmissionJournal of Virology, 2011
- Human immunodeficiency virus infection and cerebral malaria in children in Uganda: a case-control studyBMC Pediatrics, 2011
- The relationship of Plasmodium falciparum humeral immunity with HIV-1 immunosuppression and treatment efficacy in ZambiaMalaria Journal, 2009
- Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of UgandaMalaria Journal, 2009
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986